|

Half-Dose of novel OAC Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 3: 1

Top Sponsors

  • Texas Cardiac Arrhythmia Research Foundation1

Indications

Austin, Texas1 trial

Optimal Anti-Thrombotic Management Following Percutaneous Left Atrial Appendage Occlusion

Texas Cardiac Arrhythmia Institute, St. David's Medical Center

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.